Waiver to the interests for late payment by signing up to the supplier payment plan may or may not be valid
In its judgment of 16 February 2017, the Court of Justice of the European Union leaves the door open for the national court to verify whether the aforementioned waiver was freely agreed to
CAPSULAS Nº 179
Between 2008 and 2013, several companies supplied goods and provided services to medical establishments forming part of the Health Service of the Autonomous Community of the Region of Murcia, which failed to pay for those goods and services. Those companies then assigned the debts at issue to IOS Finance, a factoring company that would later... Read More
Countdown for adapting to the new European personal data protection framework
The Spanish Data Protection Agency (AEPD) publishes a range of guidelines on adapting to the General Data Protection Regulation
CAPSULAS Nº 179
The General Data Protection Regulation (GDPR), Regulation (EU) 2016/679, is the new regulatory framework adopted by the European Union on the protection of personal data. Although it was published in May 2016, it will not fully come into force until May 2018. Thereafter, both Organic Law 15/1999, on Personal Data Protection and Royal Decree 1720/2007,... Read More
Transferencias de valor e impuestos, cuestión de calidad
EL GLOBAL
Lo que está sucediendo con las transferencias de valor de la industria a los profesionales sanitarios me lleva a pensar en el equilibrio entre beneficio y riesgo que siempre hay que buscar en el mundo del medicamento; y en la necesidad de no olvidar otro elemento que también es esencial en cualquier medicamento: su calidad.... Read More
Faus & Moliner at the Early Access Programmes & Compassionate Use in the EU in Düsseldorf
Francisco Aránega made a presentation about Early access possibilities in Spain
This seminar was organized by the FORUM Institut in Düsseldorf and provided a detailed overview of early access possibilities in the EU in general as a well as in Germany, the UK, Spain and France in particular. The seminar informed about the available options for, and the arising challenges of, bringing pharmaceuticals to the European... Read More
¿Un paso atrás en la morosidad del sector público?
El Global
Muchos esperábamos con cierta expectación a que este jueves día 16 se hiciera pública la sentencia del Tribunal de Justicia de la Unión Europea (TJUE). Podría haber sido un revulsivo en la lucha contra la morosidad del sector público. Pero no pudo ser, al menos de momento.¡ La morosidad pública se ha convertido en una... Read More
Los precios fijados por el SNS y el comercio paralelo
El Global
La Comisión Nacional de los Mercados y la Competencia (CNMC) ha cerrado, esperemos que definitivamente, la discusión sobre si el sistema establecido por Pfizer en relación con el precio al cual suministraba sus medicamentos a los distribuidores españoles, incumplía o no las normas relativas a la defensa de la competencia españolas y europeas. El asunto... Read More
New developments in the access of SMEs to public tenders
Decision No. 173/2016 of the Catalan Court of Public Sector Contracts (TCCSP) of 4 November 2016 and Report of CNMC of 1 September 2016
CAPSULAS Nº 178
Background Some of the obstacles that SMEs frequently come up against when accessing public tenders are, for example, the non-division of the purpose of the contract into batches or the requirement of economic solvency related to business size. Recently, regulatory changes have been introduced and suggestions published to overcome these difficulties. We analyse one of... Read More
Veterinary centres in Andalusia may have a stock of medicinal products for human use
Judgment of the Supreme Court of 14 December 2016 on the Decree of the Regional Government of Andalusia on veterinary establishments and medicinal products
CAPSULAS Nº 178
Background This judgment derives from a previous judgment set down by the High Court of Justice of Andalusia (TSJA) on 29 September 2014, resulting from an appeal filed by the Association for Animal Health against a range of provisions in Decree 79/2011, which established rules on the distribution, prescription, dispensation and use of medicinal products... Read More
La buena regulación es un signo de progreso
EL GLOBAL
La forma de legislar de un país determina en gran medida la eficiencia (o ineficiencia) en su avance económico y social. Un buen ejemplo de ineficiencia lo tenemos en un asunto resuelto por nuestro Tribunal Supremo el pasado mes de diciembre. Dicho tribunal anulaba el Real Decreto 639/2014, regulador de la troncalidad y otros aspectos... Read More
Los descuentos de fidelidad: esperando a Intel
Cuadernos de Derecho Farmacéutico, No. 59, October-December 2016
Loyalty rebates offered subject to the condition that the customers buys all or most of its needs of a given product from a supplier, are presumed to be illegal when granted by a dominant company. The judgement of the General Court in the Intel case seems to qualify this presumption as a iuris et de... Read More